Henry Schein Inc. closed 21.76% below its 52-week high of $82.49, which the company achieved on February 5th.

Henry Schein Inc. closed 23.53% short of its 52-week high of $82.49, which the company achieved on February 5th.

Henry Schein Medical, the U.S. medical business of Henry Schein, Inc. (Nasdaq: HSIC), announced today that Ian Jeffer, MS, ...

Henry Schein provided an updated financial outlook for 2024. The company expects adjusted EPS to be in the range of $4.74-$4.82 (previously $4.70-$4.82). The revised figure reflects 5-7% growth ...

Shares of Henry Schein, Inc. (NASDAQ:HSIC – Get Free Report) reached a new 52-week low on Friday . The stock traded as low as $63.00 and last traded at $63.93, with a volume of 99296 shares traded.

Media roundtable sessions: "Conversations with Henry Schein: Exploring the Present and Future of Oral Health" will take place to discuss digitalization in dentistry; Henry Schein will also feature ...

In a report released today, Erin Wright from Morgan Stanley maintained a Sell rating on Henry Schein (HSIC – Research Report), with a price ...

Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners, and alternate sites of care worldwide. It operates through Global Distribution and ...

Henry Schein (HSIC) announced that the Science Based Targets initiative has approved the company’s near-term and long-term science-based ...

Henry Schein Medical, the U.S. medical business of Henry Schein, Inc. (Nasdaq: HSIC), has been selected by the United ...